Paper33089751
Targeting the Epithelial-to-Mesenchymal Transition in Cancer Stem Cells for a Better Clinical Outcome of Glioma.
Lu YB and 7 others. Technol Cancer Res Treat, 2020. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Targeting the Epithelial-to-Mesenchymal Transition in Cancer Stem Cells for a Better Clinical Outcome of Glioma. Papers, record 33089751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33089751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting the Epithelial-to-Mesenchymal Transition in Cancer Stem Cells for a Better Clinical Outcome of Glioma.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epithelial-Mesenchymal Transition | Major topic |
| Glioma | Major topic |
| Molecular Targeted Therapy | Major topic |
| Neoplastic Stem Cells | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Biomarkers, Tumor | |
| Clinical Studies as Topic | |
| Drug Evaluation, Preclinical | |
| Humans | |
| Signal Transduction | |
| Treatment Outcome |
Source PubMed
References105
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25578726 | Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation. | Cell Rep | 2015 | https://conductscience.org/library/papers/25578726 | PubMed |
| 2 | 25093491 | Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells. | Br J Cancer | 2014 | https://conductscience.org/library/papers/25093491 | PubMed |
| 3 | 19904829 | NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. | Stem Cells | 2010 | https://conductscience.org/library/papers/19904829 | PubMed |
| 4 | 25521330 | ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres. | Brain Pathol | 2015 | https://conductscience.org/library/papers/25521330 | PubMed |
| 5 | 22664874 | Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. | J Immunol | 2012 | https://conductscience.org/library/papers/22664874 | PubMed |
| 6 | 17051156 | Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. | Nature | 2006 | https://conductscience.org/library/papers/17051156 | PubMed |
| 7 | 23486688 | STAT3 silencing inhibits glioma single cell infiltration and tumor growth. | Neuro Oncol | 2013 | https://conductscience.org/library/papers/23486688 | PubMed |
| 8 | 19580863 | Role of IL-1 beta and COX2 in silica-induced IL-6 release and loss of pneumocytes in co-cultures. | Toxicol In Vitro | 2009 | https://conductscience.org/library/papers/19580863 | PubMed |
| 9 | 15520185 | The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. | Cancer Res | 2004 | https://conductscience.org/library/papers/15520185 | PubMed |
| 10 | 23636324 | Structure of the human smoothened receptor bound to an antitumour agent. | Nature | 2013 | https://conductscience.org/library/papers/23636324 | PubMed |
| 11 | 19921751 | Notch promotes radioresistance of glioma stem cells. | Stem Cells | 2010 | https://conductscience.org/library/papers/19921751 | PubMed |
| 12 | 17367064 | Contribution of Notch signaling activation to human glioblastoma multiforme. | J Neurosurg | 2007 | https://conductscience.org/library/papers/17367064 | PubMed |
| 13 | 18551395 | Differential expression of E-cadherin gene in human neuroepithelial tumors. | Genet Mol Res | 2008 | https://conductscience.org/library/papers/18551395 | PubMed |
| 14 | 21856686 | Role of Eph/ephrin tyrosine kinase in malignant glioma. | Neuro Oncol | 2011 | https://conductscience.org/library/papers/21856686 | PubMed |
| 15 | 22898254 | Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: modification of the core skeleton for improved solubility. | Bioorg Med Chem | 2012 | https://conductscience.org/library/papers/22898254 | PubMed |
| 16 | 21112561 | Tissue-resident adult stem cell populations of rapidly self-renewing organs. | Cell Stem Cell | 2010 | https://conductscience.org/library/papers/21112561 | PubMed |
| 17 | 18772113 | Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18772113 | PubMed |
| 18 | 20418909 | ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. | Oncogene | 2010 | https://conductscience.org/library/papers/20418909 | PubMed |
| 19 | 24291104 | Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant. | Eur J Pharmacol | 2014 | https://conductscience.org/library/papers/24291104 | PubMed |
| 20 | 24900187 | Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist. | ACS Med Chem Lett | 2010 | https://conductscience.org/library/papers/24900187 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41353504 | Restoring the glioblastoma tumor microenvironment by targeting C5a with the antagonist W54011. | Sci Rep | 2025 | https://conductscience.org/library/papers/41353504 | PubMed |
| 36338770 | Emerging trends and research foci of epithelial-mesenchymal transition in gliomas: A scientometric analysis and review. | Front Oncol | 2022 | https://conductscience.org/library/papers/36338770 | PubMed |
| 35986010 | Exosomal miR-155-5p derived from glioma stem-like cells promotes mesenchymal transition via targeting ACOT12. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35986010 | PubMed |
| 35957872 | Paeoniflorin Inhibits EMT and Angiogenesis in Human Glioblastoma via K63-Linked C-Met Polyubiquitination-Dependent Autophagic Degradation. | Front Oncol | 2022 | https://conductscience.org/library/papers/35957872 | PubMed |
| 35628507 | The Protein L-Isoaspartyl (D-Aspartyl) Methyltransferase Regulates Glial-to-Mesenchymal Transition and Migration Induced by TGF-β1 in Human U-87 MG Glioma Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628507 | PubMed |
| 35459783 | Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner. | Oncogene | 2022 | https://conductscience.org/library/papers/35459783 | PubMed |
| 35204054 | Molecular Mechanisms and Clinical Challenges of Glioma Invasion. | Brain Sci | 2022 | https://conductscience.org/library/papers/35204054 | PubMed |
Genes43
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33089751
GET https://conductscience.org/api/papers/v1/33089751/references?page=2